Weight loss itself can shift thyroid hormone requirementsas body composition changes, the volume of distribution for thyroid medications shrinks, potentially causing hormone levels to rise
Beyond their antidiabetic effects, DPP-IV inhibitors have exhibited additional properties that make them potentially valuable in oncology
PF-06882961 is orally bioavailable and efficacious for lowering glucose and food intake in monkeys The pharmacokinetics of PF-06882961 were examined in rats and monkeys after intravenous (IV) and oral administration (Fig 5A, Table S7)
This study explored whether GLP-1RA use in T2DM was associated with a reduction in CRC risk
In a mouse model of T2DM, GLP-1 and exendin-4 were unable to stimulate skeletal muscle glucose uptake and glycogen storage due to the reduced expression of AKT in these cells [102]
Glucagon-like peptide 1 (GLP-1) is a substance produced by the body from a gene called pre-proglucagon